Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Catalio Capital Management, LP (CIK 1958125) reported $478.7M across 37 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: DNTH ($47.0M, 9.82%), BBIO ($32.1M, 6.70%), ASND ($29.5M, 6.17%), BMY ($25.5M, 5.33%), SNDX ($24.4M, 5.09%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | $47.0M | 9.82% | 560,308 | Trimmed |
| 2 | BBIO | BRIDGEBIO PHARMA INC | $32.1M | 6.70% | 432,014 | New |
| 3 | ASND | ASCENDIS PHARMA A/S | $29.5M | 6.17% | 129,111 | Added |
| 4 | BMY | BRISTOL-MYERS SQUIBB CO | $25.5M | 5.33% | 420,727 | Trimmed |
| 5 | SNDX | SYNDAX PHARMACEUTICALS INC | $24.4M | 5.09% | 1.0M | Trimmed |
| 6 | GILD | GILEAD SCIENCES INC | $22.8M | 4.77% | 163,905 | Trimmed |
| 7 | TERN | TERNS PHARMACEUTICALS INC | $21.6M | 4.50% | 409,031 | Added |
| 8 | DEFINIUM THERAPEUTICS INC | $19.6M | 4.10% | 1.0M | New | |
| 9 | SLNO | SOLENO THERAPEUTICS INC | $19.3M | 4.04% | 577,808 | Added |
| 10 | BSX | BOSTON SCIENTIFIC CORP | $18.8M | 3.92% | 299,318 | Trimmed |
| 11 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $17.8M | 3.72% | 850,797 | Added |
| 12 | INCY | INCYTE CORP | $17.1M | 3.58% | 182,101 | New |
| 13 | CYTK | CYTOKINETICS INC | $14.2M | 2.97% | 215,501 | Trimmed |
| 14 | NTRA | NATERA INC | $14.2M | 2.96% | 70,907 | Added |
| 15 | CRVS | CORVUS PHARMACEUTICALS INC | $13.0M | 2.73% | 891,933 | New |
| 16 | GPCR | STRUCTURE THERAPEUTICS INC | $12.3M | 2.57% | 255,379 | Added |
| 17 | MLYS | MINERALYS THERAPEUTICS INC | $11.9M | 2.48% | 439,041 | Added |
| 18 | EW | EDWARDS LIFESCIENCES CORP | $11.6M | 2.42% | 144,607 | Trimmed |
| 19 | VERADERMICS INC | $11.0M | 2.29% | 173,582 | New | |
| 20 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $10.0M | 2.10% | 722,784 | Trimmed |
| 21 | HEARTFLOW INC | $9.8M | 2.05% | 403,588 | Added | |
| 22 | KALV | KALVISTA PHARMACEUTICALS INC | $8.6M | 1.79% | 426,551 | New |
| 23 | QURE | UNIQURE NV | $8.0M | 1.68% | 491,116 | Added |
| 24 | IRON | DISC MEDICINE INC | $7.9M | 1.64% | 122,978 | Added |
| 25 | SEPN | SEPTERNA INC | $7.1M | 1.48% | 294,360 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31